Rocky Mountain Cancer Centers — Littleton, Colorado

Rocky Mountain Cancer Centers is a clinical research site located in Littleton, Colorado, United States 80120-4413.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers has participated in 22 clinical trials with 4 currently active.

Therapeutic areas: Metastatic Renal Cell Carcinoma, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Platinum-resistant Ovarian Cancer.

Sponsors: Pfizer, Hoffmann-La Roche, Laekna Limited.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers?

Rocky Mountain Cancer Centers has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers conducted?

Rocky Mountain Cancer Centers has 22 clinical trials on record, with 4 currently active. Their work covers Metastatic Renal Cell Carcinoma, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Platinum-resistant Ovarian Cancer.

Is Rocky Mountain Cancer Centers accredited by Crixeo Health?

Yes — Rocky Mountain Cancer Centers holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rocky Mountain Cancer Centers?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.